Breethe Abiomed Recovery RegisTry (BART)
Launched by ABIOMED INC. · Jul 22, 2022
Trial Information
Current as of August 02, 2025
Completed
Keywords
ClinConnect Summary
No description provided
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • all adult subjects supported with Breethe Oxy-1 System
- Exclusion Criteria:
- • subjects under 18 years of age
About Abiomed Inc.
Abiomed Inc. is a leading medical technology company specializing in heart pump and circulatory support devices. With a commitment to advancing patient care, Abiomed develops innovative therapies designed to treat coronary artery disease and heart failure, significantly improving patient outcomes. The company is renowned for its cutting-edge Impella heart pumps, which provide temporary mechanical support for patients undergoing high-risk procedures or experiencing severe cardiovascular events. Through rigorous clinical trials and a dedication to research and development, Abiomed aims to transform the landscape of cardiovascular treatment and enhance the quality of life for patients worldwide.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Houston, Texas, United States
Atlanta, Georgia, United States
New York, New York, United States
Orlando, Florida, United States
College Park, Maryland, United States
Philadelphia, Pennsylvania, United States
Patients applied
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials